| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 29, 2005
Accepted on January 17, 2006
Endocrinology Department of Medical Sciences "M. Aresu" and Department of Cytomorphology San Giovanni di Dio Hospital, University of Cagliari, Cagliari, Italy
* To whom correspondence should be addressed. E-mail: mariotti{at}pacs.unica.it.
Objective: Serum thyroglobulin (Tg) is the marker of differentiated thyroid carcinoma (DTC) after total thyroidectomy, but its value is limited by the interference of anti-Tg antibodies (TgAb). Detection of Tg in fine-needle aspiration biopsy (Tg-FNAB) wash-out fluid is used to identify neck DTC recurrences/metastases, but the interference of serum TgAb in this procedure is unknown.
Subjects and methods: Seventy-three patients (41 after surgery for thyroid cancer and 32 with thyroid nodules) evaluated for suspicious cervical lymph nodes were retrospectively reviewed. Tg was assayed by IRMA or chemiluminescent assay in ultrasound-guided FNAB used for cytology. Serum TgAb were detected by passive agglutination or chemiluminescent assay. On the basis of preliminary data obtained in lymphoadenitis, Tg-FNAB >36 ng/ml and >1.7 ng/ml (in presence or absence of thyroid gland, respectively) was considered as indicative of metastasis.
Results: In 51 TgAb-negative patients, Tg-FNAB was positive in 15 (12 with malignant and 3 with not-diagnostic cytology), all with histologically confirmed DTC metastases. Of the remaining 36 patients with negative Tg-FNAB, 30 had not-suspicious and 6 suspicious cytology. Histology of the latter showed 4 undifferentiated thyroid cancer metastases and 2 lymphoadenitis. In 22 TgAb-positive patients, Tg-FNAB was positive in 14 (12 with malignant and 2 with not-diagnostic cytology), all with histologically confirmed DTC metastases.
Conclusions: Clinical performance of Tg-FNAB appears to be not substantially affected by TgAb and this procedure remains superior to cytology in the identification of DTC neck metastases. However, cytology should always be performed, since, irrespectively form TgAb, Tg is undetectable in FNAB from undifferentiated metastases.
This article has been cited by other articles:
![]() |
A. Corrias, A. Cassio, G. Weber, A. Mussa, M. Wasniewska, A. Rapa, R. Gastaldi, S. Einaudi, F. Baronio, M. C. Vigone, et al. Thyroid Nodules and Cancer in Children and Adolescents Affected by Autoimmune Thyroiditis Arch Pediatr Adolesc Med, June 1, 2008; 162(6): 526 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Borel, R. Boizel, P. Faure, G. Barbe, J. Boutonnat, N. Sturm, D. Seigneurin, I. Bricault, J.-P. Caravel, P. Chaffanjon, et al. Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer Eur. J. Endocrinol., May 1, 2008; 158(5): 691 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. H. Snozek, E. P. Chambers, C. C. Reading, T. J. Sebo, J. W. Sistrunk, R. J. Singh, and S. K. G. Grebe Serum Thyroglobulin, High-Resolution Ultrasound, and Lymph Node Thyroglobulin in Diagnosis of Differentiated Thyroid Carcinoma Nodal Metastases J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4278 - 4281. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Giovanella and A. Ghelfo Undetectable Serum Thyroglobulin Due to Negative Interference of Heterophile Antibodies in Relapsing Thyroid Carcinoma Clin. Chem., October 1, 2007; 53(10): 1871 - 1872. [Full Text] [PDF] |
||||
![]() |
N. Cunha, F. Rodrigues, F. Curado, O. Ilheu, C. Cruz, P. Naidenov, M. J. Rascao, J. Ganho, I. Gomes, H. Pereira, et al. Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer Eur. J. Endocrinol., July 1, 2007; 157(1): 101 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boi, I. Maurelli, G. Pinna, F. Atzeni, M. Piga, M. L. Lai, and S. Mariotti Calcitonin Measurement in Wash-Out Fluid from Fine Needle Aspiration of Neck Masses in Patients with Primary and Metastatic Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2115 - 2118. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |